SEC Filing Document

Company: Ambitious Entertainment, Inc.
Ticker: 
CIK: 1900851
Filing Type: S-1
Document Type: S-1
Date Filed: 2026-05-15
Accession Number: 0001493152-26-023581
Exchange: 
SIC Code: 7812
SIC Description: Services-Motion Picture & Video Tape Production
URL: https://www.sec.gov/Archives/edgar/data/1900851/000149315226023581/forms-1.htm

Chunk 17 of 57
Word Count: 1464
Character Count: 9133

Document Content:

the prior written consent of the underwriters, during the period ending 180 days from the date of this offering, directly or indirectly, offer to sell, sell, pledge or otherwise transfer or dispose of any of shares of our common stock, enter into any swap or other derivatives transaction that transfers to another any of the economic benefits or risks of ownership of shares of our common stock, make any demand for or exercise any right or cause to be filed a registration statement, including any amendments thereto, with respect to the registration of any shares of common stock or securities convertible into or exercisable or exchangeable for shares of common stock or any other our securities or publicly disclose the intention to do any of the foregoing. There can be no assurance that we enter into anticipated agreements with actors, directors, or other creative talent, following completion of this offering.

have engaged in preliminary discussions with certain actors, directors, and other creative talent regarding potential collaborations
and other business relationships. However, these discussions are preliminary in nature, and we have not entered into binding agreements
with respect to these matters. There can be no assurance that we will enter into definitive agreements with any of these individuals
on favorable terms, or at all, including following the completion of this offering.

Our
ability to enter into definitive agreements with such talent depends on numerous factors, many of which are beyond our control, including
the availability and scheduling commitments of such individuals, the terms and conditions we are able to negotiate, and competition.

we are unable to finalize agreements with some or all of the talent with whom we have had discussions, we may be unable to produce certain
content that we have planned or announced, or we may be required to seek alternative talent on less favorable terms or with less market
appeal. Any of these outcomes could have a material adverse effect on our business, financial condition, results of operations, and prospects.

USE
OF PROCEEDS

estimate that the net proceeds from our issuance and sale of shares of our common stock in this offering will be approximately $[●]
million, after deducting underwriting discounts and commissions and estimated offering expenses payable by us, or $[●] million
if the underwriters exercise their over-allotment option in full.

currently expect to use the net proceeds of this offering for working capital, offering expenses, and other general corporate purposes,
including the creation of a dedicated development fund to transform IP into television series or movies.

may also use a portion of the proceeds from this offering to acquire or invest in additional intellectual property and to expand our
development pipeline. We have not allocated specific amounts of net proceeds for any of these purposes.

The
company intends to attract higher profile and more valuable IP as well as develop new and existing IP into franchises that would include
sequels, spin-offs, prequels, animated versions, and video games by building on the company’s current relationship with Netflix,
which is poised to become a major player in online video games.

Each
$1.00 increase or decrease in the assumed public offering price of $4.50 per share, the midpoint of the estimated initial public
offering price range set forth on the cover of this prospectus, would increase or decrease the net proceeds to us from this offering
by approximately $[●], assuming that the amount of shares of common stock offered by us, as set forth on the cover page of this
prospectus, remains the same, and after deducting underwriting discounts and commissions payable by us. We may also increase or decrease
the number of shares of common stock we are offering. An increase or decrease of [●] shares of common stock offered by us in this
offering would increase or decrease the net proceeds to us by approximately $[●], assuming that the assumed price per share to
the public remains the same, and after deducting underwriting discounts and commissions payable by us. We do not expect that a change
by these amounts in the initial public offering price or the common stock offered by us would have a material effect
on our uses of the proceeds from this offering, although it may accelerate the time at which we will need to seek additional capital.

Assuming
the maximum amount of shares of common stock are sold by us, we expect that the net proceeds, together with our existing cash and cash
equivalents, will enable us to fund our operating expenses and capital expenditure requirements for at least [●] months.
In addition, we have granted to the underwriters an option to purchase up to an additional 533,333 shares
of common stock, exercisable for 45 days from the date of this prospectus, solely to cover over-allotments, if any. We
will use the proceeds from the sale of these additional shares for working capital and general corporate purposes.

The
expected use of net proceeds represents our intentions based upon our current plans and business conditions, which could change in the
future as our plans and business conditions evolve and change. The amounts and timing of our actual expenditures, specifically with respect
to working capital, may vary significantly depending on numerous factors. As a result, our management will retain broad discretion over
the allocation of such net proceeds.

addition, we plan to invest these proceeds in short-term investments until needed for the uses described above.

The
dedicated development funds invested by the company are recoupable with a 50% return at the time a project is developed and successfully
greenlit for production by a streaming site or studio. The fund is designed to reinvest these funds as received on an expected cash flow
timeline of up to 18 months per investment. The dedicated development funds over the 18 months cycle are designed to continue to be reinvested
in new IP development, starting a new 18-month cycle utilizing the same funds.

DIVIDEND
POLICY

have not historically declared dividends on our common stock, and we do not currently intend to pay dividends on our common stock. The
declaration, amount and payment of any future dividends on shares of our common stock, if any, will be at the sole discretion of our
board of directors, out of funds legally available for dividends. We anticipate that we will retain our earnings, if any, for the growth
and development of our business.

CAPITALIZATION

The
following table sets forth our cash and cash equivalents and our capitalization as of December 31, 2025 as follows:

an actual basis, and

a pro forma basis after giving effect to 130,000 shares of Series
A Preferred Stock issued in the Bridge Financing in April 2026.

a pro forma as adjusted basis after giving effect to the sale and issuance of shares
of common stock pursuant to this public offering at an initial public offering price of $4.50
per share, the midpoint of the estimated initial public offering price range set forth on
the cover page of this prospectus, after deducting the underwriting discounts and commissions
and estimated offering expenses payable by us.

You
should read the following table in conjunction with “Use of Proceeds”, “Management’s Discussion and Analysis
of Financial Condition and Results of Operations” and our financial statements and related notes included elsewhere in this prospectus.

Actual Pro
Forma Pro
Forma As Adjusted

Cash $	1,070 $	97,070 $

Total indebtedness 4,482,724 4,162,724

Stockholders’ Equity:

Preferred stock, $0.0001 par value; 1,000,000 shares authorized;

237,341 shares
issued and outstanding on an actual basis and 367,341 shares issued and outstanding on a pro forma basis, 367,341 shares
issued and outstanding on a pro forma as adjusted basis, as of December 31, 2025, respectively 24 37

Common stock, $0.0001 par value; 150,000,000 shares authorized;

11,492,500 shares
issued and outstanding on an actual basis and 11,492,500 shares issued and outstanding on a pro forma basis, 15,048,056
shares issued and outstanding on a pro forma as adjusted basis, as of December 31, 2025, respectively 1,149 1,149

Additional paid-in capital 227,068 227,068

Accumulated deficit (14,619,181	) (14,619,181	)

Total Stockholders’
Equity $	(14,390,940	) $	(14,390,926	) $

Total Capitalization $	(9,908,217	) $	(10,228,203	) $

DILUTION

you invest in our common stock, your interest will be diluted to the extent of the difference between the public offering price per share
paid by purchasers of shares in this offering and the pro forma as adjusted net tangible book value per share of our common stock immediately
after the completion of this offering.

Our
historical net tangible book value (deficit) as of December 31, 2025 was $(14,640,940) or $(1.25) per share of common
stock. Our historical net tangible book value (deficit) per share represents our total tangible assets less our total liabilities, divided
by the shares of common stock outstanding as of December 31, 2025.